The link between anti-ApoA-I autoantibodies of immunoglobulin G (IgG) class and CVD was first noted in studies of patients with autoimmune diseases [9–13] and initially linked to a loss of atheroprotective HDL functions [9–11]. This evidence concerns the gene APOA1 and autoimmune disease.